1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, October 2016 (p50)

Biotechnology Analysis & Statistics, October 2016 (p50)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1471-1500 of about 3300 reports

Purchase Reports From Reputable Market Research Publishers

Pulmatrix Inc

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Pulmatrix Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : United States, World

3D Cell Culture - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $375.25 million in 2015 and is expected to reach $1520.15 million by 2022 growing at a CAGR of 22.1% during the forecast ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World

Sterile Filtration - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Sterile Filtration Market is accounted for $4.12 billion in 2015 and is expected to reach $9.57 billion by 2022 growing at a CAGR of 12.7% during the forecast period. ...

  • Industries : Biotechnology
  • Countries : World, North America, Asia, Europe

Drug Discovery Technologies - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. ...

  • Industries : Genomics
  • Countries : World, Asia, Europe, North America

Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight

  • $ 1000
  • Industry report
  • October 2016
  • by PNS Pharma

“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in clinical pipeline. Currently ...

  • Industries : Biopharmaceutical, Therapy

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States

Aptamers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Aptamers market is expected to grow from $109.23 million in 2015 to reach $346.14 million by 2022 with a CAGR of 17.9%. Huge R&D investments in bio-tech companies ...

  • Industries : Biotechnology
  • Countries : World, North America, Asia, Europe

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Allergy Immunotherapy Market is poised to grow at a CAGR of around 8.2% from 2015 to 2025. Some of the prominent trends that the market is witnessing include unmet need for healthcare in developing ...

  • Industries : Biological Therapy
  • Countries : United States

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • October 2016
  • by GlobalData

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline ...

  • Industries : Pathology, Healthcare, Drug Discovery and Development
  • Countries : United States

Genotyping - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Genotyping market is estimated at $6.43 billion in 2015 and is expected to reach $24.36 billion by 2022 growing at a CAGR of 21% from 2015 to 2022. Growing awareness ...

  • Industries : Genomics
  • Countries : World, Asia, Europe, North America

Cancer Biomarkers - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. ...

  • Industries : Genomics
  • Countries : World, Asia, Europe, North America

Single-Cell Analysis - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Single-Cell Analysis market is estimated at $1.22 billion in 2015 and is expected to reach $4.25 billion by 2022 growing at a CAGR of 19.5% from 2015 to 2022. Growing ...

  • Industries : Biological Therapy
  • Countries : World, Asia, Europe, North America

Epigenetics - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Epigenetics market is accounted for $500 million in 2015 and is expected to reach $1,286 million by 2022 growing at a CAGR of 14.4% from 2015 to 2022. Growing prevalence ...

  • Industries : Genomics
  • Countries : World, Asia, Europe, North America

Biopreservation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biopreservation Market is accounted for $2.17 billion in 2015 and is expected to reach $4.75 billion by 2022 growing at a CAGR of 11.84% during the forecast period. ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

  • Industries : Biopharmaceutical, Generic Drug, Pharmaceutical
  • Countries : World, Asia, Europe, North America

Genome Editing - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Genome Editing market is estimated at $2098.9 million in 2015 and is expected to reach $5367.64 million by 2022 growing at a CAGR of 14.3% from 2015 to 2022. Increasing ...

  • Industries : Genetically Modified Organism
  • Countries : World, Asia, North America, Europe

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 220
  • Industry report
  • October 2016
  • by La Merie Publishing

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • $ 1200
  • Industry report
  • October 2016
  • by PNS Pharma

“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently there are ...

  • Industries : Therapy

Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)

  • $ 900
  • Industry report
  • October 2016
  • by Daedal Research

Scope of the Report The report titled “Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global biopreservation market by value and by segments. ...

  • Industries : Genomics
  • Countries : World

Stem Cell Banking - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. ...

  • Industries : Biological Therapy
  • Countries : World

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States

Global Dental Bone Graft Substitutes Market Analysis & Trends Product (Osteograf, Bio OSS, Grafton), Graft Type (Allograft, Synthetic Bone Graft, Demineralized, Allograft, Xenograft), Application - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Dental Bone Graft Substitutes Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $990.3 million by 2025. Some of the prominent trends that the market ...

  • Industries : Advanced Material, Biomaterial, Biomaterial
  • Countries : United States

Global Personalized Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 3495
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Personalized Medicine Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the ...

  • Industries : Genomics
  • Countries : United States

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • $ 1500
  • Company report
  • October 2016
  • by PNS Pharma

“Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Herceptin drug in clinical pipeline. Currently there ...

  • Industries : Therapy, Biopharmaceutical, Oncology

Enbrel Biosimilars Clinical Trial Insight

  • $ 1500
  • Company report
  • October 2016
  • by PNS Pharma

“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars ...

  • Industries : Biopharmaceutical

Global Cancer Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Cancer Diagnostics Partnering 2010-2016 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Healthcare, Diagnostics, Cancer, Health Services, Pharmaceutical, Pathology, Genomics
  • Countries : United States

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin 8 Receptor A or IL8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine ...

  • Industries : Therapy, Biological Therapy
  • Countries : United States, World

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis (LCA) - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha ...

  • Industries : Therapy
  • Countries : Europe, United States, World

Biocon Limited - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

Biocon Limited - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Biocon Limited - Product Pipeline Review - 2016’, provides an overview of the Biocon Limited’s pharmaceutical research ...

  • Industries : Therapy
  • Countries : World, India

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.